For further details see:
Cerevel Therapeutics, Avinger leads healthcare gainers; DiaMedica Therapeutics, MediWound among major losersFor further details see:
Cerevel Therapeutics, Avinger leads healthcare gainers; DiaMedica Therapeutics, MediWound among major losersMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Sensei Biotherapeutics Inc. Company Name:
SNSE Stock Symbol:
Market:
2024-05-13 18:15:04 ET Stephens analyst issues OVERWEIGHT recommendation for SNSE on May 13, 2024 04:20PM ET. SNSE was trading at $1.57 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 2 - Buy recommendati...
2024-05-13 18:00:03 ET Sudan Loganathan from Stephens issued a price target of $5.00 for SNSE on 2024-05-13 16:20:00. The adjusted price target was set to $5.00. At the time of the announcement, SNSE was trading at $1.57. The overall price target consensus is at $6.00 wi...
- Completed SNS-101 monotherapy and combination dose escalation through 15mg/kg with no dose limiting toxicities - - Company to present topline clinical data from the SNS-101 Phase 1 dose escalation study at the 2024 ASCO Annual Meeting - - Enrollment in the dose expansion...